Clinical Trial Update: To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effect of perampanel on sleep in individuals with insomnia and partial-onset epilepsy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Partial-onset Epilepsy

Drugs mentioned

• Perampanel (perampanel)

Snippet

Sponsor: Eisai Inc. | Conditions: Epilepsy, Partial | Phase 4 | Status: WITHDRAWN